ANGLF
IM Cannabis Corp.
Healthcare · Drug Manufacturers - Specialty & Generic · IL
Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
SummaryUpdated Jun 1, 2026
IM Cannabis Corp. (NASDAQ:IMCC) is an Israeli-based medical cannabis company founded in 2016 that has evolved from a multi-market operator to a focused player in the German and Israeli medical cannabis markets. The company went public in May 2020 and is headquartered in Tel Aviv-Yafo, Israel. After initially expanding into Canada, IM Cannabis has strategically refocused its operations on the more promising European and Middle Eastern markets, particularly capitalizing on Germany's cannabis legalization in April 2024.
Latest newsMore news →
IM Cannabis Corp. entered into a letter of intent to sell its European-focused assets to Slil.com Holding Ltd.94d agoIM Cannabis Corp. filed a resale registration statement on Form F-3 with the SEC, registering 17,276,931 common shares for resale.103d agoIM Cannabis Corp. closed a US$225,000 convertible note financing in a private placement with an institutional investor.109d ago